Moderna (MRNA) Gains 5% as Biotech Sector Seeks New Growth Catalysts | Insider Buying

SpaceX~$1TSpaceX~$1T

More insights

Stock Lists

All Stock Lists

Tech
Biotech
Blue Chip
FAANG
Gold
Large Cap
Oil
REITs
Small Cap
Warren Buffett

Investing Tools

Calendars and Tools

Analyst Ratings
Top Analysts
Congressional Trading
Dividends
Earnings
Insider Trades
Top Movers
Portfolio Monitoring
Short Interest
Sector Performance
Stock Screener

Search Headlines

Daily insider intelligence sourced from SEC Form 4 filings, the Federal Reserve, U.S. Treasury, CFTC, Bank of Canada, and Statistics Canada — distilled into the Insider Score.

Market Data

Top Insider Scores
Insider Trades
Top Gainers
Congressional Trades
Stock Heatmap

Stock Lists

Penny Stocks
Large Cap
FAANG
Warren Buffett
All Stocks

Research

Intro to Insider Buying
Insider Access
For Business / API
Contact Us

Data sources

SEC EDGAR
Federal Reserve
U.S. Treasury
Bank of Canada

© 2026 insiderbuying. All rights reserved.

Terms & Conditions Privacy Policy Cookie Settings Disclosures Disclaimer Corrections

Not investment advice. The Insider Score summarises publicly available SEC Form 4 filings and is provided for informational purposes only. Always conduct your own research and consult a licensed financial professional before making any investment decision.

Moderna (MRNA) Gains 5% as Biotech Sector Seeks New Growth Catalysts | Insider Buying